BREAKING
Home » Posts Tagged "Basilea Pharmaceutica"

Ceftobiprole, single treatment for multiple common infections, to undergo Phase 3 clinical studies

By

A broad spectrum antibiotic that could become the first of its kind to treat specific Gram negative and Gram positive infections as well as tularemia, a bioterrorism threat, will undergo the last steps...

New antibiotic, Zevtera, launched in Germany for treatment of bacterial lung infections

By

PRESS RELEASE Basilea Pharmaceutica Ltd. announced  Friday that its broad-spectrum antibiotic, Zevtera® (ceftobiprole medocaril) has been launched in Germany. The European Centre for Disease Prevention...

Isavuconazole designated QIDP in the US for the treatment of invasive candidiasis, Basilea seeks additional approval in EU for treatment of invasive mold infections

By

Basilea Pharmaceutica Ltd. reported this week that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the oral and intravenous treatment...